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Abstract
Objective: In low- and middle-income countries, bloodstream infections are an important cause of mortality in patients with
burns. Increasingly implicated in burn-associated infections are highly drug-resistant pathogens with limited treatment
options. We describe the epidemiology of bloodstream infections in patients with burns in a humanitarian surgery project in
Iraq.
Methods: We performed a retrospective, descriptive study of blood culture isolates identified between July 2008 and
September 2009 among patients with burns in a single hospital in Iraq who developed sepsis.
Results: In 1169 inpatients admitted to the burn unit during the study period, 212 (18%) had suspected sepsis, and 65 (6%)
had confirmed bacteremia. Sepsis was considered the primary cause of death in 198 patients (65%; 95% CI 65–70) of the 304
patients that died. The most commonly isolated organisms were Pseudomonas aeruginosa (22 isolates [34%]),
Staphylococcus aureus (17 [26%]), Klebsiella pneumoniae (8 [12%]), Staphylococcus epidermidis (7 [11%]), Acinetobacter
baumannii (6 [9%]), and Enterobacter cloacae (5 [8%]). A high proportion of Enterobacteriaceae strains produced extended-
spectrum beta-lactamase and S. aureus isolates were uniformly methicillin-resistant. For gram-negative bacteria, the most
reliably active antibiotics were imipenen and amikacin.
Conclusions: Burn patients with sepsis in Iraq were commonly found to have bloodstream pathogens resistant to most
antibiotics available locally. Effective empirical therapy of burn sepsis in this region of Iraq would consist of vancomycin or
teicoplanin and a carbapenem-class antibiotic with antipseudomonal activity.
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Introduction
Infection remains the leading cause of morbidity and mortality
among patients with burns in developing and conflicted-affected
countries [1]. The treatment and prevention of infection among
burn patients presents a particularly difficult challenge in these
contexts. The emergence of highly drug-resistant bacterial
pathogens in burn patients represents an alarming new develop-
ment, with invasive bloodstream infections of particular concern
[2]. However, descriptions of the epidemiology of bloodstream
infections in burn patients from these regions – data that could
potentially improve management strategies – remain scarce.
From 2007 to 2009, Me´decins Sans Frontie`res/Doctors
Without Borders (MSF) supported a regional referral burn care
center in Sulaymaniyah, part of the Kurdistan region of Iraq
(Figure 1). As part of this medical support, an on-site clinical
microbiology laboratory was established to improve empirical
antibiotics in burn sepsis, to refine clinical decision-making for
individual patients, and to improve the understanding of the
epidemiology of burn infection in this region.
A study of burns arising from the conflicts in Iraq and
Afghanistan described the importance – in burn-associated
bacteremia in this region – of Pseudomonas aeruginosa, Klebsiella
pneumoniae, Acinetobacter calcoaceticus-baumannii complex, and
Staphylococcus aureus, frequently with multidrug-resistant pattern.
In the study, multidrug-resistant organisms were associated with
increased mortality, with the largest impact on mortality seen with
Klebsiella pneumonia [3]. In a recent report from Iran, among
patients hospitalized with burn injuries, Klebsiella pneumoniae
carbapenemase (KPC) was detected in hospitalized burn patients
with an associated 33% mortality rate [4].
Materials and Methods
Study Setting
In the aftermath of the US military intervention in Iraq, the
epicenter of the conflict remained too insecure for the establish-
ment of a medical humanitarian surgical project. As a result, MSF
opened several projects outside of the high-conflict zone, including
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support for a surgical teaching hospital in Sulaymaniyah, with
specialization in the treatment of patients with burns. During the
period of collaboration from July 2007 to November 2009
between MSF and the Directorate of Health (DOH), the number
of patients with burns represented approximately 50–100 admis-
sions per month (2168 admissions).
Standard Care
All patients arriving to the emergency department were scored
for burn severity and area of involvement affected using the
Wallace ‘‘rule of nines,’’ and medical resuscitation was initiated.
During this period, only patients with burn injuries .10% of total
body surface area (TBSA) were admitted. Early eschar excision
Figure 1. Map of Iraq showing area of Sulaymaniyah.
doi:10.1371/journal.pone.0101017.g001
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and grafting was not routinely performed. Initial eschar debride-
ment typically occurred on day 3 or 4, typically followed by
delayed skin grafting. Topical antimicrobial therapy consisted
primarily of silver sulfadiazine. Systemic antibiotics were not given
prophylactically, except perioperatively at which time a single dose
was given, but were initiated when burn sepsis or severe local burn
infection was suspected. Burn sepsis was defined according to
established criteria [5]. Patients with suspected sepsis underwent
blood culture collection prior to empirical antibiotic initiation.
When burn sepsis was suspected, antibiotics were initiated, using
an empirical regimen (vancomycin plus gentamicin or pipericillin/
tazobactam plus amikacin) and were adjusted once blood culture
results were available approximately 5 days later.
Study Design
We performed a retrospective descriptive study of burn patients
with sepsis syndrome identified at the Sulaymaniyah burn center
between July 1, 2008 and September 1, 2009. All burn patients
with suspected sepsis who underwent a blood culture series were
included. A blood culture series consisted of at least 1 specimen of
blood (adults: 10 ml, children’s: 2.5–5 ml) obtained from veni-
puncture for sequential inoculation of bottled media (Aerobic only)
in a 24 hour period. Medium bottle stoppers were cleaned with a
70% isopropyl alcohol wipe, which was left in place prior to
inoculation [6]. Any repeat sample with the same bacteria on
more than one occasion from the same patient was not included in
the study. A blood culture was considered to be contaminated if
one or more of the following organisms were identified in only one
of a series of blood culture specimens: coagulase-negative
Staphylococcus species, Propionibacterium acnes, Micrococcus
species, viridans group streptococci, Corynebacterium species, or
Bacillus species.
Burn patients from several inpatient departments were included
in the study: two intensive care units for adults and children with
acute injuries, and two recovery burn wards providing step-down
care. Demographic and clinical data were extracted systematically
from patient files using standardized instrument.
Blood cultures were processed by a manual standard method
(Hemoline performance diphasic, bioMerieux, Marcy l’Etoile,
France). Isolates were identified by conventional biochemical
Table 1. Patient demographics and type of injury.
Demographic/Type N (%)
Gender 1,169
Male 374 (32)
Female 795 (68)
Age
0–5 362 (31)
6–14 141 (12)
15–29 362 (31)
30–59 257 (22)
$60 47 (4)
Mechanism of injury
Fire/flame 421 (36)
Scalding 631 (54)
Contact 82 (7)
Other 35 (3)
Place of injury
Home (including yard) 970 (83)
Work 129 (11)
School/outdoors 70 (6)
Alleged intent of injury
Accidental, self 946 (81)
Accidental, other 129 (11)
Intentional, self 82 (7)
Intentional, other 12 (1)
% TBSA burned (median 18%, IQR 9.5–39.0)
#15 338 (29)
15–30 468 (40)
31–50 234 (20)
51–69 82 (7)
$70 47 (4)
Hours between injury and presentation (median, IQR) 1, (0.5–1.5)
TBSA, total body surface area.
doi:10.1371/journal.pone.0101017.t001
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methods according to standard microbiological techniques and
commercially available kits (API; bioMerieuxVitek, Inc., Hazel-
wood, MO) [7]. Antibiotic susceptibility was determined by using
Kirby Bauer disk diffusion recommended by the Clinical
Laboratory Standard Institute [8] and ATB expression, a semi-
automatic method (bioMe´rieux, Marcy l’Etoile, France). Methi-
cillin-resistant Staphylococcus aureus (MRSA) and Enterobacteri-
aceae producing extended-spectrum beta-lactamase (ESBL) were
confirmed using phenotyping methods [9]. The interpretation of
resistance and susceptibility to antimicrobials was determined
using CLSI 2008 recommendations [9].
Bacterial etiology and associated drug-resistance profiles were
entered into WHONET, a software database tool created by the
World Health Organization for antimicrobial resistance surveil-
lance [10]. For external quality control (EQA), half of the isolates
were sent to an accredited laboratory in Jordan (Ibn Al Haytham
Hospital, Amman, Jordan) for confirmation of bacteria identifica-
tion and antibiotic susceptibility testing using the MicroScanWalk-
Away system (Dade Behring, Deerfield, IL).
We defined a multidrug-resistant isolate as any of the following:
(1) ESBL-expressing Enterobacteriaceae (Escherichia coli, Klebsi-
ella spp., Enterobacter cloacae, Proteus spp.); (2) Pseudomonas
Table 2. Patient care outcomes and mortality.
Outcome N (%)
N=1169
Length of hospital stay: median 8 days, IQR 3–14
Admission outcome
Recovery 772 (66)
Death 303 (26)
Discharged against medical advice 94 (8)
Cause of death
Inhalation injury 106 (35)
Sepsis 198 (65)
Mortality by % TBSA burned
#15 0 (n/a)
15–30 70 (15% died)
31–50 119 (51% died)
51–69 78 (95% died)
$70 47 (100% died)
Proven bacteremia (n = 65) by % TBSA burned (median 59%, IQR 36.5–77.0)
#15 0 (n/a)
15–30 11 (18% sepsis)
31–50 20 (30% sepsis)
51–69 34 (52% sepsis)
$70 0 (n/a)
TBSA, total body surface area.
doi:10.1371/journal.pone.0101017.t002
Table 3. General bacteria etiology among blood culture isolates.
Organism N=65
n %
Gram-negative bacteria 41 63
Gram-positive bacteria 24 37
Specific organisms identified
Pseudomonas aeruginosa 22 33
Staphylococcus aureus 17 26
Klebsiella pneumoniae 8 12
Acinetobacter baumannii 9 14
Staphylococcus epidermidis 7 11
Enterobacter cloacae 5 8
doi:10.1371/journal.pone.0101017.t003
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aeruginosa and Acinetobacter baumannii isolates non-susceptible
to at least one agent in three or more antimicrobial categories
typically used for treatment; or (3) MRSA and coagulase-negative
Staphylococcus (identified in .1 separate specimen). These
definitions are consistent with recommendations proposed in
2011 by a panel of international experts [11]. Permission to
conduct the study was granted by the regional Department of
Health of Sulaymaniyah province.
Results
Between July 1, 2008 and September 1, 2009, 1169 patients
were admitted to the hospital, at a rate of approximately 80–100
patients per month. A total of 795 (68%) patients were female, and
the most commonly affected age groups were young adults 15–29
years (31%) and children 0–5 years (31%). Burn characteristics are
described in detail below (Table 1).
We analyzed 389 blood samples among 212 patients with
suspected sepsis. Among these 212 patients, 65 (31%) had a proven
bloodstream infection with the causative agent cultured from
blood samples, while 112 (53%) patients had negative blood
cultures. Thirty-five (16%) patients had blood samples that were
consistent with our definition of contamination. The 65 patients
with proven bacteremia represented 6% of the 1169 total
inpatients treated in the burn center during the study period.
Median number of positive blood cultures per person in those with
any positive blood cultures was 1.5 (IQR, 1–2); no case of
polymicrobial bacteremia were observed. Forty-four (68%) of the
65 patients with positive blood cultures were in the adult burn
unit, 10 (15%) patients in the pediatric unit, and 11 (17%) in
recovery units (step-down care). Bloodstream infection rates rose
by TBSA involved in burn (Table 2). Proven bacteremia was
observed in 11 (18%) patients with 15–30% TBSA involved, 20
(30%) with 31–50% TBSA involved and 34 (52%) with 51–69%
TBSA involved.
The median hospital admission duration was 8 days (IQR, 3–
14). An overall mortality rate of 26% (95% CI, 24–29%) was
observed (Table 2). Mortality was considered by TBSA involved: 0
(0%) among patients presented with ,15% BSA involvement, 70
patients (15%) with 15–30% TBSA, 119 patients (51%) with 31–
51% TBSA, 125 patients (97%) with .51% BSA.
Gram-negative organisms represented 41 (63%) of 65 overall
isolates (Table 3). The most common gram-negative organisms
were Pseudomonas aeruginosa (34%), Klebsiella pneumoniae
(12%), Acinetobacter baumannii (9%), and Enterobacter cloacae
(8%). Gram-positive bacteria represented 24 (37%) of 65 of overall
isolates. The most common gram-positive organisms were
Staphylococcus aureus (26%) and Staphylococcus epidermidis
(11%). Forty-eight (74%) of 65 patients were found to have a
multidrug-resistant organism including 63% of the gram-negative
isolates (Table 3). ESBL-expression was observed in 8 of 13
Enterobacteriaceae isolates.
Among gram-negative bacteria, the most reliably active drugs
were imipenem and amikacin which were active against 83% and
61% of isolates, respectively (Table 4). Overall 92% of gram-
positive isolates were multidrug-resistant (Table 5) reflecting the
prominent role of MRSA bloodstream infections in this patient
population. Among S. aureus, three more reliably active drugs
were vancomycin, rifampicin, and clindamycin, which were active
against 100%, 71%, and 65% of isolates, respectively (Table 6). A
high level of concordance was noted among 47 samples that were
sent to the reference laboratory (Unweighted Cohen Kappa 0.92,
IC 95 [0.90–0.94]).
Discussion
We report a high prevalence of multidrug-resistant strains
notably Pseudomonas aeruginosa, ESBL-expressing Enterobacte-
riaceae, and MRSA among patients with burn-associated bacter-
emia in northern Iraq. Our report confirms and strengthens prior
data describing causes of burn-related bacteremia in this region
Table 4. Resistance profile for gram-negative bacteria.
Organisms K.pneumoniae E. cloacae P. aeruginosa A. baumannii
N=8 N=5 N=22 N=6
n (%R) n (%R) n (%R) n (%R)
Ampicillin/Sulbactam 1 (17)
Amoxicillin/Clavulanic ac 4 (50)
Ticarcillin/Clavulanic ac 8 (100) 5 (100) 16 (73) 5 (83)
Piperacillin 5 (100) 14 (64) 6 (100)
Piperacillin/Tazobactam 7 (87) 2 (40) 9 (41) 4 (67)
Cephalothin (CIG) 8 (100)
Cefuroxime (CIIG) 8 (100) 5 (100)
Ceftazidime (CIIIG) 7 (87) 5 (100) 12 (54) 4 (67)
Cefepime (CIVG) 4 (50) 4 (80) 7 (32) 3 (50)
Gentamicin 8 (100) 4 (80) 21 (95) 6 (100)
Amikacin 6 (75) 1 (20) 5 (23) 4 (67)
Ciprofloxacin 5 (62) 1 (20) 14 (64) 3 (50)
Co-trimoxazole 4 (50) 4 (80)
Imipenem 0 (0) 0 (0) 5 (23) 2 (33)
Colistin 0 (0) 0 (0)
doi:10.1371/journal.pone.0101017.t004
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[12]. The high prevalence of multidrug-resistant organisms gives
serious cause for concern particularly because most isolates are
resistant to the antimicrobial agents generally used in the region
for empirical treatment of burn sepsis. Importantly, the use of
blood culture samples illustrates that multidrug-resistant organisms
are not merely skin or wound colonizers but in this region are the
dominant cause of invasive bloodstream infections in burn
patients.
In contrast to resource-rich settings, where S. aureus is the most
common cause of burn-associated bacteremia and sepsis, gram-
negative bacteremia was shown to be common in this region of
Iraq [13,14]. Gram-negative infections are frequently lethal in
burn patients in resource-limited settings [15], particularly where
early excision and grafting is not routinely practiced and access to
appropriate intravenous antimicrobials is lacking.
Based on these findings from burn patients with suspected sepsis
in this region, where basic hygiene, isolation, and early excision
may be lacking, the use of empirical therapy combining a
carbapenem and an aminoglycoside such as amikacin may be
warranted. The use of this regimen could potentially be supported
by a mortality study performed in the same burn unit in 2007,
which described a mortality rate of 20% of patients with burn-
associated sepsis [16].
This study has several strengths. The use of blood cultures
helped to show the presence of multidrug-resistant organisms in
invasive burn infections. The microbiology laboratory adhered to
international standards, and a reference laboratory was employed
for quality control. A high level of concordance was noted for
samples sent to the reference laboratory. The study also has several
weaknesses. We were unable to correlate blood isolates with
severity and patient outcomes owing to a lack of data linking
isolates with patient characteristics such as burn TBSA area
involvement and mortality. The study was retrospective, and
cultures were obtained at the discretion of the attending surgeons,
which allowed for the possibility of sampling bias. Such a bias
could have resulted in the inclusion of more severely ill patients
and exclusion of less severely ill patients.
The introduction of clinical microbiology capacity in this
northern Iraq burn hospital was advantageous in several ways. In
patients with less-resistant pathogens, the introduction of micro-
Table 6. Resistance profile of Gram-positive bacteria.
Organism S. aureus S. epidermidis
N=17 N=7
n (%R) n (%R)
Penicillin G 17 (100) 7 (100)
Oxacillin 17 (100) 5 (71)
Gentamicin 15 (88) 2 (29)
Fusidic acid 12 (71) 3 (43)
Levofloxacin 10 (59) 1 (14)
Clindamycin 6 (35) 0 (0)
Minocycline 5 (29) 1 (14)
Rifampin 5 (29) 0 (0)
Quinupristin/Dalfopristin 2 (12) 0 (0)
Nitrofurantoin 0 (0) 0 (0)
Vancomycin 0 (0) 0 (0)
doi:10.1371/journal.pone.0101017.t006
Table 5. Proportion of blood culture isolates that were multidrug-resistant.
Organism Multidrug-resistant isolates
n/N %
Gram-negative bacteria 26/41 63
Gram-positive bacteria 22/24 92
Specific organisms identified
Pseudomonas aeruginosa 14/22 64
Staphylococcus aureus 17/17 100
Klebsiella pneumoniae 4/8 50
Acinetobacter baumannii 4/9 67
Staphylococcus epidermidis 5/7 71
Enterobacter cloacae 4/5 80
Total multidrug-resistant organisms 48/65 74
doi:10.1371/journal.pone.0101017.t005
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biology laboratory capacity allowed for the simplification of
therapy once the specific pathogen was isolated. Moreover, the
aggregated culture data, with the use of WHONET software,
allowed physicians to improve the choice of initial antibiotics in
patients with suspected burn sepsis pending microbiology results.
The culture data helped the hospital order drugs in a more
rational way. Although routine microbiology is an expensive
undertaking for humanitarian surgical projects, these data suggest
there is added value in acquiring microbiology data to improve
treatment strategies and the understanding of antibiotic resistance
in poor and conflict-affected settings.
Infection control must be prioritized in burn units in Iraq to
potentially halt or reverse the rapid evolution of antibiotic
resistance. Selection and cross-transmission of antibiotic-resistant
pathogens occurs readily in inpatient burn units in the developing
world. Basic hygiene standards are often not observed uniformly in
inpatient burn units in resource-limited settings, creating condi-
tions favoring the cross-transmission of drug-resistant bacteria.
More research is needed on strategies to reduce colonization and
infection with multidrug-resistant organisms in contexts where
early excision and grafting are not routine, space constraints are
great, and access to disposable materials is limited.
We found that multidrug-resistant organisms were common
invasive pathogens in burn-injury patients with bacteremia in
northern Iraq. Burn treatment programs in Iraq and similar
regions, whether operated by nongovernmental organizations or
by the government, must respond with appropriate use of
antimicrobials and invest additional resources in hospital infection
control and surveillance of antibiotic resistance. Our results
demonstrated that on-site microbiology, although costly, provided
critical data for refining individual patient care through more
rational use of antimicrobials and improved empirical treatment of
burn-associated sepsis in this region.
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